Industry
Collaboration and Licensing Agreement Expanded to Exploit Isoforms as Diagnostic Markers
Pressure BioSciences and Target Discovery are expanding their strategic license agreement and collaboration in support of TDI'S planned offering of personalized medicine, clinical diagnostic services. More...07 May 2012
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
In Other News
Cancer Testing Market to Experience Better Than Average Growth
Current Opportunity and Future Potential of Personalized Medicine
Rubicon Genomics Enters Cancer Diagnostics Agreement with Agendia
OGT Enters Licensing Agreement for Twelve Colorectal Cancer Biomarkers
Analytica 2012 Live Lab Takes Visitors into the World of Laboratories
Signal Genetics Expands Oncology Pipeline with Acquisition of ChipDX
Rusnano and Magnisense to Collaborate on Advanced Diagnostic Systems
Life Technologies and DaAn Gene Form Joint Diagnostic Business
Waters and Tecan Sign Agreement for Clinical Assay Platform
Ventana and Bayer to Collaborate on Companion Diagnostic
Gen-Probe Acquires GTI Diagnostics for USD 53 Million
Qiagen and Max Planck to Develop TB Molecular Diagnostic
Ventana and Syndax to Develop Companion Diagnostic
Quest Increases Presence in New Mexico with S.E.D. Labs Acquisition
MDx and M&A Markets Experience Lull in Late 2011
Hemoglobin A1c Test to Be Provided in Retail Pharmacies
Affymetrix Will Acquire eBioscience for USD 330 Million
Biohit Oyj Sells Liquid Handling Business to Sartorius
Ventana and ACD Promote In Situ RNA Hybridization Assay
Gentronix and BioQuanta to Distribute Mitoxis-Functional Metabolic Platform.
Clarient and Acorn Collaborate on Tumor Molecular Testing
Abbott Expands Agreement with GlaxoSmithKline to Develop Companion Diagnostic
IVD Market Expected to Grow Substantially in 2012-2014
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
